Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004721.pdf 0001562180-25-004721.rtf 0001562180-25-004721.xls View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004723.pdf 0001562180-25-004723.rtf 0001562180-25-004723.xls View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004724.pdf 0001562180-25-004724.rtf 0001562180-25-004724.xls View HTML
June 11, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004722.pdf 0001562180-25-004722.rtf 0001562180-25-004722.xls View HTML
June 5, 2025	4	Statement of changes in beneficial ownership of securities	0001562180-25-004491.pdf 0001562180-25-004491.rtf 0001562180-25-004491.xls View HTML
May 8, 2025	8-K	Report of unscheduled material events or corporate event	0001517022-25-000027.pdf 0001517022-25-000027.rtf 0001517022-25-000027.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 8, 2025	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-25-023460.pdf 0001628280-25-023460.rtf 0001628280-25-023460.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 30, 2025	SCHEDULE 13G	SCHEDULE 13G - Description	0000932471-25-000479.pdf 0000932471-25-000479.rtf 0000932471-25-000479.xls View HTML
April 29, 2025	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001517022-25-000023.pdf 0001517022-25-000023.rtf 0001517022-25-000023.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 29, 2025	DEFA14A	Additional proxy soliciting materials - definitive	0001517022-25-000024.pdf 0001517022-25-000024.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax